Total Funding
35
Total FundingSeries B raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
56674
Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.
Acquired by 
Ceva Santé Animale
Mark Heffernan: Chief Executive OfficerPast Role: Nexvet, Co-Founder & CEO
Krishna Polu: President & CEOPast Role: CytomX Therapeutics, Chief Medical Officer
About the Company
Scout Bio is a biotechnology company that specializes in veterinary, animal health, and gene therapy. The company is driven by its mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine.
Scout Bio was founded in 2016 and headquartered in Pennsylvania, United States.
